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Purpose: To compare the results obtained by two screening techniques for diabetic 
retinopathy.
Methods: Patients were assessed in two groups, according to whether the retinal images were 
analyzed by the general practitioner (Group 1) or by the ophthalmologist (Group 2) in a   two-year 
prospective study using telemedicine.
Results: The number of patients referred to the nonmydriatic fundus camera unit was higher 
in Group 1 than in Group 2 (63.80% versus 17.63%). Greater patient adherence was observed 
in Group 1 than in Group 2 when patients came to retinography (98.25% versus 87.52%). 
There were no significant differences in other technique variables. The prevalence of diabetic 
  retinopathy was similar in both groups (8.98% in Group 1 and 9.16% in Group 2), but the 
prevalence of severe proliferative diabetic retinopathy was higher in Group 2 (1.69% [severe] 
and 0.45% [proliferative]) than in Group 1 (1.01% and 0.11%, respectively). Diabetic macular 
edema was more prevalent in Group 2 (2.03%).
Conclusions: The inclusion of general practitioners in the screening method seems to be 
  important. A great number of patients with diabetes mellitus were screened, and a higher 
  percentage of patients with diabetic retinopathy or macular edema were detected.
Keywords: nonmydriatic fundus camera, diabetic retinopathy, diabetes mellitus, diabetic 
macular edema, diabetic retinopathy, epidemiology
Introduction
Diabetes mellitus is a chronic disease that affects approximately 180 million people 
around the world.1 In 1997, the diagnostic criteria were revised by the World Health 
Organization, which recognized the two-hour glucose level as a good standard for 
diagnosis of diabetes, but indicated that a fasting plasma glucose .7.0 mmol/L 
(126 mg/dL) can be accepted as a satisfactory alternative in epidemiologic studies.2,3 
These new diagnostic criteria changed the number of patients included as having Type 
2 diabetes mellitus and prompted an expected rise estimated at 300 million cases by 
the year 2025.
In the Spanish population, the prevalence of diabetes has risen from 6% in the 
1990s to higher than 12% in the most recent studies, meaning that there are currently 
about 4.3 million people with diabetes in Spain. These patients are controlled by family 
physicians or general practitioners, at primary health care centers, each of which has 
a dependent population of about 25,000. The general practitioners refer patients to an 
ophthalmologist for ocular fundus control and for diabetic retinopathy screening.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Several different screening methods have been tested, but 
the most accepted method for community-based screening 
is retinal photography by nonmydriatic fundus camera. The 
advantages of this method are becoming increasingly clear, 
and include low-cost screening, the possibility of extending 
the screening program to a lot of people with diabetes rela-
tively quickly, taking away the subjectivity in the diagnosis, 
and being able to maintain accurate records of previous 
retinal appearances.4,5
Since 2005, screening has been done by nonmydriatic 
fundus camera in our area. Initially, an   ophthalmologist 
  evaluated all retinographies, but in January 2007 we 
  introduced evaluation by general practitioners, as the primary 
diagnostic professionals, although in only half of the primary 
health care centers. This new method seems to be efficient, 
as we have reported previously.6
The aim of the present study was to compare the results 
from a two-year prospective study (2008–2009), using two 
different techniques of diabetic retinopathy screening. The 
first includes diagnosis by the general practitioners using 
telemedicine, assisted by an ophthalmologist in the event of 
a doubtful retinography, and the second including the reading 
of all retinographies by an ophthalmologist.
Methods
study setting
Hospital Universitari de Sant Joan is the only   surgical 
  ophthalmology center in Reus, Spain, with 218,740   inhabitants, 
and all diabetes patients referred by general practitioners to 
the hospital are examined once a year by the   ophthalmology 
service. The prevalence of diabetes mellitus in the 
  population over 14 years of age is estimated at 8%; a total 
of 12,146 patients are considered to have the disease. This 
study is based on Type 2 diabetes mellitus only; patients 
with Type 1 were excluded because since 1991 all Type 1 
diabetes patients have been screened annually at the hospital 
by endocrinologists and ophthalmologists.
Design
Patients were classified in two groups. In Group 1, screening 
for diabetic retinopathy was done by 73 general practitioners 
in seven of the 12 primary health care centers in our area 
(R-I, R-II, R-III, R-IV, PR-I, PR-II, PR-III). These areas 
represent a total of 113,396 inhabitants including 7133 reg-
istered   diabetics. A description of this population has been 
published previously.6 In Group 2, screening for   diabetic 
retinopathy was done by an ophthalmologist, and the results 
were sent on to the general practitioners. This group included 
62 general practitioners in five of the 12 primary health care 
centers in our area (R-V, PR-IV, PR-V, PR-VI, PR-VII). 
These areas represent a total of 105,344 inhabitants including 
5013   registered diabetics.
There were no demographic, social, or economic 
  differences between the two populations, and urban and rural 
areas were distributed evenly across both groups.
In 2006, prior to the program, the general practitioners in 
Group 1 were given a short course in the theory and practice 
of fundus eye exploration and diagnosis that is normally 
  carried out by a retina specialist at the ophthalmology service. 
In the two groups, the same financial incentives were offered 
to the general practitioners to refer patients for diabetic 
retinopathy screening. A total of 4551 patients in Group 1 
and 884 in Group 2 were examined by nonmydriatic fundus 
camera between 01 January 2008 and 31 December 2009.
screening techniques
Group 1 patients were referred by their general practitioners 
to the retina fundus camera unit located at one health care 
center (R-I). A technician was specifically trained to take 
photographs without pupil dilatation (except in cases where 
this was not possible, when a drop of tropicamide 0.5% 
was given). The retinographies were sent to the general 
  practitioners for diagnosis. If the images were pathologic (in 
his or her opinion) the general practitioner sent the images 
on to the referring ophthalmologist, who evaluated them and 
reported back to the general practitioner, having decided 
if the patient needed a secondary study or treatment at the 
ophthalmology retina unit at the hospital.
Group 2 patients were referred by their general practitio-
ners to the retina fundus camera unit located at one health care 
center (R-V) as for Group 1. A technician was   specifically 
trained to take photographs without pupil dilatation (except in 
cases where this was not possible, when a drop of   tropicamide 
0.5% was given). However, diagnosis was then made by 
the ophthalmologist, who sent a report of the status of the 
fundus to the general practitioner, recommending or not a 
secondary study or treatment in the ophthalmology retina 
unit at the hospital.
Both groups referred to the same ophthalmologist. 
He read the doubtful retinographies in Group 1 and all 
  retinographies in Group 2. The retina was photographed 
using a unit equipped with a TOPCON TRC-NW6S fundus 
camera. Two nonstereoscopic 45° photographs were taken 
of each eye, according to the EURODIAB recommended 
protocol; two photographs in two fields were taken, the first 
centered on the temporal to the macula and the second on Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1483
Diabetic retinopathy screening
the nasal to the papilla.7 Age, type, duration, and treatment 
of diabetes, and any history of arterial hypertension, as well 
as HbA1c and lipid levels, were recorded.
Diagnosis and classification  
of diabetic retinopathy
Diabetic retinopathy is diagnosed when at least four or more 
microaneurysms are present in the fundus photograph, with or 
without hard or soft exudates, in the absence of other known 
causes of the changes (eg, branch retinal vein occlusion).
According to a modified version of the American 
  Academy of Ophthalmology classification,8,9 seven grades 
of severity were established, ie, nondiabetic retinopathy, 
mild nonproliferative diabetic retinopathy, moderate 
  nonproliferative diabetic retinopathy, severe nonprolifera-
tive diabetic retinopathy, proliferative diabetic retinopathy 
without high-risk characteristics, proliferative diabetic 
retinopathy with high-risk characteristics, and patients 
treated previously with laser. Because the presence of retinal 
thickening with no hard exudates is difficult to detect from 
our nonstereoscopic digital images, grading of maculopathy 
was based on the presence of exudates in the macular region. 
The existence of hard exudates at 500 microns from the 
fovea was considered to be diagnostic of macular edema in 
the present study.
statistical methods
All statistical analyses were carried out using the SPSS 
software package version 15.0. Results were expressed as 
mean ± standard error, and a P value ,0.05 was considered 
to indicate statistical significance. Differences between 
those included in the analysis were examined using two 
sample   Student t-tests or Kruskal-Wallis for continuous or 
  quantitative variables, such as visual acuity or current age. 
For the qualitative or categorical variables, we used the 
Chi-square test in the univariate phase of the study, with 
determination of the odds ratio for each variable.
Variables included in the study were presence of   diabetic 
retinopathy, presence of diabetic macular edema, and 
  presence of any lesion in the macular area (eg, age-related 
maculopathy, macular degeneration, myopia, epiretinal 
membranes).
Results
In Group 1, 4551 patients were screened. The mean age 
was 64.52 ± 12.46 years (40–91 years), with 2093 men 
(45.98%) and 2458 women (54.08%, Table 1). The mean 
duration of diabetes mellitus was 7.56 ± 4.09 (1–30) years. 
Arterial hypertension was present in 2585 patients (56.80%). 
Diabetes was treated with insulin in 1282 patients (28.17%). 
In Group 2, 884 patients were screened. Mean age was 
64.47 ± 12.13 years (38–90 years), with 403 men (45.51%) 
and 481 women (54.42%). Mean duration of diabetes mel-
litus was 7.54 ± 4.12 (1–25) years. Arterial hypertension was 
present in 499 patients (56.45%). Diabetes was treated with 
insulin in 229 patients (25.90%)
In Group 1, general practitioners referred 4632 patients 
(64.93%) to the fundus camera unit, of whom 4551 attended 
the visit (98.25%), representing 63.80% of all patients 
  registered as diabetic (Tables 2 and 3). Pupil dilatation 
was necessary in 1229 cases (27.00%). For 97 patients 
(2.13%), it was not possible to interpret the fundus image, 
so the image was referred to an ophthalmologist for fur-
ther examination under slit-lamp biomicroscopy. There 
were 2.92 ± 0.67   photographs taken of each patient to 
obtain the best quality retinography. General practitioners 
Table 1 Demographic and metabolic data for the patients at the end of two years
Group 1 Group 2 Significance (P)
Total patients screened  4551 884
Male/female 2093/2458
(45.99%/54.01%)
406/478
(45.93%/54.07%)
0.127 
Age (mean ± sD) 64.52 ± 12.46
(40–91 years)
64.47 ± 12.13
(38–90 years)
0.157 
Diabetes duration (mean ± sD) 7.56 ± 4.09
(1–30 years) 
7.54 ± 4.12
(1–25 years) 
0.213 
Arterial hypertension 2594 (56.99%) 495 (55.99%) 0.112 
Diabetes treatment
Diet 473 (16.99%) 144 (16.28%) 0.113
Oral 2594 (56.99%) 495 (55.99%) 0.332
insulin 1184 (26.02%) 245 (27.71%) 0.241
hbA1c 7.64 ± 1.34 7.54 ± 1.08 0.316
Abbreviations: sD, standard deviation; hba1c, glycosylated hemoglobin.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Table 2 Different results between screening methods, data after two years (01 January 2008 to 31 December 2009)
Group 1 (n = 4551) Group 2 (n = 884) Significance (P)
number of patients referred to the screening/number  
of patients registered as diabetic
4632/133 (64.93%) 1010/5013 (20.14%) ,0.001
number of patients screened/number  
of patients registered as diabetic
4551/7133 (63.80%) 884/5013 (17.63%) ,0.001
number of patients screened/number  
of patients referred
4551/4632 (98.25%) 884/1010 (87.52%) ,0.001
number of patients who did not 
attend the retinography 
81/4632 (1.75%) 126/1010 (12.47%) ,0.001
no visualization of retinography 60/4551 (2.15%) 18/884 (2.04%) 0.228
Pupil dilatation needed 1229/4551 (27.00%) 238/884 (26.92%) 0.113
number of retinographies per eye  2.92 ± 0.67 2.87 ± 0.65 0.103
number of patients referred to the ophthalmology  
service after screening 
387/4551 (8.50%) 77/884 (8.71%) 0.073
Retinography waiting list 15.23 ± 3.12 days 14.12 ± 2.98 days 0.127
Table 3 Index of referred patients to the nonmydriatic fundus camera during the two-year study, and subclassified into two groups 
according to primary health care center
R-I 
Urban
R-II 
Urban
R-III 
Urban
R-IV 
Urban
PR-I 
Rural
PR-II 
Rural
PR-III 
Rural
Total
Group 1
Registered  
diabetic patients
1064 1916 1492 1382 170  416 693 7133
2008 272 (25.56%) 556 (29.01%) 310 (20.77%) 544 (39.36%) 31 (18.23%) 94 (22.60%) 209 (30.15%)  2016 (28.26%)
2009 400 (37.59%) 667 (34.81%) 466 (31.23%) 639 (46.23%) 35 (20.58%) 101 (24.27%) 227 (32.75%) 2535 (35.54%)
Total (two-year  
summary)
672 (63.16%) 1223 (63.83%) 776 (52%) 1183 (85.60%) 66 (38.82%) 195 (46.87%) 436 (62.91%) 4551 (63.80%)
Group 2 R-V 
Urban
PR-IV 
Rural
PR-V 
Urban
PR-VI 
Urban
PR-VII 
Rural
Total
Registered 
diabetic patients
1735 401  1792 730 355 5013
2008 131 (9.10%) 111 (34.16%) 157 (10.26%) 56 (8.70%) 13 (3.30%) 468 (9.33%)
2009 130 (10.23%) 72 (22.08%) 206 (13.76%) 7 (1.01%) 1 (0.34%) 416 (8.29%)
Total (two-year  
summary)
261 (19.33%) 183 (56.24%) 363 (24.02%) 63 (9.71%) 14 (3.64%) 884 (17.63%)
referred the retinographies of 956 patients (21.01%) to the 
  consultant   ophthalmologist. Of those, the ophthalmologist 
sent on 409 patients (8.98%) to the retina section of the 
ophthalmology service for the correct diagnostic procedure 
and treatment. In Group 2, general practitioners referred 
1010 patients (20.14%) to the fundus camera unit, of whom 
884 attended the visit (87.52%), representing 17.63% of 
all patients registered as diabetic. Pupil dilation was neces-
sary in 238 patients (26.92%). For 19 patients (2.14%), it 
was not possible to interpret the fundus image, and these 
patients needed referral to the ophthalmologist for further 
examination under slit-lamp biomicroscopy. There were 
2.87 ± 0.65 photographs taken of each patient to obtain the 
best quality retinography. Of those, general practitioners 
referred 79 patients (8.93%) to the ophthalmology service 
for the correct diagnostic procedure and treatment.
In Group 1, diabetic retinopathy was diagnosed in 
409 patients (8.98%) and diabetic macular edema in 
60 patients (1.32%). Diabetic retinopathy was classified as 
mild in 227 patients (4.98%), 88 patients (1.93%) presented 
with moderate diabetic retinopathy, 46 patients (1.01%) had 
severe diabetic retinopathy, and only five patients (0.11%) 
had a proliferative form of the disease (Table 4). There were 
43 (0.94%) patients previously treated by laser. In Group 2, 
diabetic retinopathy was diagnosed in 81 patients (9.16%) 
and diabetic macular edema in 18 patients (2.03%). Diabetic 
retinopathy was classified as mild in 43 patients (4.86%), 
moderate in 17 (1.92%), severe in 13 (1.47%), and four Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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patients (0.45%) had a proliferative form of the disease. There 
were four (0.45%) patients previously treated by laser.
In 470 patients (10.32%) in Group 1 we observed retinal 
pathologies different from diabetic retinopathy (Table 5). 
The most frequent were lesions compatible with age-related 
macular degeneration in 82 patients (1.80%), drusen in the 
macular area in 109 patients (2.39%), hypopigmented and 
hyperpigmented lesions in the macular area in 49 patients 
(1.07%), and lesions in the macular area in 290 (6.37%) 
patients (including diabetic macular edema, age-related 
macular degeneration, age-related maculopathy, drusen, 
myopia, and epiretinal membranes). The group of patients 
with pupillary dilatation showed no differences in the diag-
noses observed. In Group 2, we observed retinal pathologies 
different from diabetic retinopathy in 96 patients (10.86%). 
The most frequent were lesions compatible with age-related 
macular degeneration in 16 patients (1.81%), drusen in the 
macular area in 21 patients (2.37%), hypopigmented and 
hyperpigmented lesions in the macular area in 11 patients 
(1.24%), and lesions in the macular area in 58 (6.56%) 
patients (including diabetic macular edema, age-related 
macular degeneration, age-related maculopathy, drusen, 
myopia, epiretinal membranes). The group of patients with 
pupillary dilatation showed no differences in the diagnoses 
observed.
Each of the tables shows statistically significant differ-
ences between the two groups. There were no differences 
according to age and gender or in arterial hypertension or 
treatment of diabetes. There were differences between the 
groups with respect to adherence to the scheduled visit to the 
nonmydriatic fundus camera unit (Tables 2 and 3). A greater 
number of patients registered as diabetics were screened in 
Group 1, and more of those patients attended the visits.
Table 4 shows that the prevalence of diabetic retinopathy 
was similar in both groups, with no significant differences 
(P = 0.081). However, statistical analysis revealed some 
  differences between the groups. In Group 2, the worst forms of 
diabetic retinopathy (severe diabetic retinopathy and prolifera-
tive diabetic retinopathy) were more prevalent. There were also 
differences in the number of patients undergoing laser treatment, 
which was higher in Group 1. There were no significant differ-
ences between the groups with regard to other pathologies.
Discussion
Systematic screening for diabetic retinopathy has been 
i  dentified as a cost-effective use of health service resources, 
Table 4 Classification of patients with diabetic retinopathy and diabetic macular edema
Type of DR Group 1 
(n = 4551) 
n (%) of patients
Group 2 
(n = 884)
n (%) of patients
Significance (P) between 
groups 1 and 2 
Mild 227 (4.98%) 41 (4.63%) 0.062
Moderate 88 (1.93%) 17 (1.92%) 0.175
severe 46 (1.01%) 15 (1.69%) ,0.001 
Proliferative  5 (0.11%) 4 (0.45%) ,0.001 
LTP 43 (0.94%) 4 (0.45%) 0.02
Total with DR 409 (8.98%) 81 (9.16%) 0.081 
DMe* 60 (1.32%) 18 (2.03%) ,0.001 
Note: *DMe: patients’ included as DMe were included in the total DR data, and distributed according to its severity. 
Abbreviations: DMe, diabetic macular edema; DR, diabetic retinopathy; LTP, treatment with laser.
Table 5 Other types of retinal lesions observed in the study, showing statistical differences between groups
Pathology Group 1  
(n = 4551)
Group 2 
(n = 884)
Significance (P) between   
groups 1 and 2 
n (%) of patients n (%) of patients
Age-related macular 
degeneration
82 (1.80%) 16 (1.81%) 0.113 
Macular drusen 109 (2.39%) 21 (2.37%) 0.201 
Periphery drusen 56 (1.23%) 10 (1.13%) 0.112 
hypo-/hyperpigmented 
lesions
49 (1.07%) 11 (1.24%) 0.060 
Myopia in macular area 50 (1.09%) 10 (1.13%) 0.097
Other diagnoses 127 (2.79%) 28 (3.16%) 0.250 
Total 470 (10.32%) 96 (10.86%) 0.140 Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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with national screening programs based on digital photography 
being implemented across Europe.10–12,16 The previous system 
included the referral of all diabetes patients to the hospital, 
retinography by a technician, and the study of all images 
and subsequent reporting by an ophthalmologist.13–15 The 
inclusion of general practitioners in the screening program 
might help us to avoid excessive referrals of patients to 
hospital. In a previous study, we demonstrated that, after 
correct training and direct support by an ophthalmologist in 
close collaboration with the general practitioner, the screen-
ing of diabetic retinopathy could be undertaken by primary 
health care centers.6 This study describes a system that has 
given general practitioners the responsibility for referring 
any pathologic retinal images to a retina specialist via the 
virtual private network common to any primary care unit 
and hospital ophthalmology service. This new development 
may help us to approach diabetes control by fundus camera 
through primary care health professionals and may involve 
general practitioners.
In this study, we have used the EURODIAB protocol 
which recommends two photographs in two 45° fields, the 
first centered on the temporal to the macula and the second 
on the nasal to the papilla, which has proven effective in 
diabetic retinopathy screening in other studies.7,16,17 The 
demographic characteristics of the two groups were similar, 
and are consistent with the literature on diabetes mellitus.18 
This similarity has allowed us to compare the groups and 
study them statistically.
We can see in Table 3 that 4551 patients (63.80% of all 
registered diabetics) in Group 1 were screened versus just 
884 (17.63%) in Group 2. This is surprising, if we consider 
that the financial incentives and the waiting list for screening 
are similar in both groups. We do not believe that the urban 
or rural origin of the patients influenced the results, because 
both groups had a similar demographic distribution. We can 
suppose that the greater involvement of general practitioners 
in the Group 1 cohort has made an observable difference.
Table 2 also presents data that is similar for both groups, 
but with differences in the number of patients requiring pupil 
dilatation, number of retinographies per eye, and number of 
patients referred to the ophthalmology service. However, 
these differences are not statistically significant.
The prevalence of diabetic retinopathy is similar in both 
groups and not statistically significant. Taking into account 
the percentage of patients with diabetic retinopathy, we 
observed that the prevalence was 8.37% in Group 1 and 
9.16% in Group 2. These levels are inferior to those in other 
published cross-sectional studies,18,19 but we should point 
out that the screening was carried out in diabetic patients 
who had not been diagnosed previously, because the latter 
were being monitored by the ophthalmology department. 
Furthermore, in studies with similar methods, such as that 
published by Soulié-Strougar in France,20 the prevalence of 
diabetic retinopathy was found to be 8.57%.
In the present study, there were some differences in 
the severity of diabetic retinopathy between the groups. 
Group 1 had fewer patients with severe and proliferative 
diabetic   retinopathy, which was significant in statistical 
analysis (P = 0.04 for severe diabetic retinopathy and 
P , 0.001 for proliferative diabetic retinopathy). There 
was also a   significant difference (P = 0.04) in the number 
of patients who had laser treatment (0.94% in Group 1 
versus 0.79% in Group 2). Finally, diabetic macular edema 
was more prevalent in Group 2 (2.03% versus 1.32% in 
Group 1), and the   differences are also significant in statistical 
analysis. Although we could detect the influence of general 
  practitioners in Group 1, due to the small number of patients 
screened in Group 2 (17.63%), we cannot rule out that any 
change in a single patient to a more severe form of diabetic 
retinopathy may have altered the outcome.
It is important that severe and proliferative forms of 
diabetic retinopathy are correctly diagnosed by general 
  practitioners and that the patients with these deleterious 
forms of the disease, which may cause marked deterioration 
in visual acuity, are treated promptly in an ophthalmology 
department. Important in this study was the diagnosis of 
  supposed diabetic macular edema. It is noteworthy that, of 
all cases detected with the nonmydriatic fundus   camera, 
the   diagnosis of clinically significant macular edema 
was confirmed by biomicroscopy, and that focal laser 
  photocoagulation was carried out in those patients. The 
diagnosis of diabetic macular edema is important because 
it is the leading cause of blindness in patients with Type 2 
diabetes mellitus. Despite some studies describing the spon-
taneous disappearance of diabetic macular edema in up to 
30% of cases,21,22 we think it is important to detect and treat 
these types of diabetic macular lesions. Furthermore, it is 
important that patients with severe macular lesions, such 
as age-related macular degeneration, macular drusen, and 
myopia in the macular area, are correctly diagnosed by 
general practitioners.
Finally, we should bear in mind that if we extrapolate 
the results and consider that 63.80% of patients with dia-
betes mellitus were screened in Group 1, we may surmise Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1487
Diabetic retinopathy screening
that in Group 2 as many as 203 patients with diabetic 
retinopathy were not detected (78 of them with severe or 
proliferative diabetic retinopathy), and 42 patients with 
diabetic edema macular went undetected, which may have 
caused the loss of visual acuity in about 120 patients in 
Group 2.
In diseases for which diagnosis is based mainly on 
imaging, as in diabetic retinopathy, the contribution of 
new imaging technology is essential. The possibility of 
using nonmydriatic cameras allows interaction between the 
different health care professionals who examine patients 
with diabetes. The differences between the two methods 
of screening do seem to be important, and the inclusion of 
general practitioners in the diagnosis of diabetic retinopathy 
appears to be advantageous. It is important to note that, in the 
present study, the 73 participating general practitioners from 
135 in our area were chosen at random and were not selected 
according to any specific criteria, although they were given 
special training in order to be able to evaluate the images. 
The results are more significant in view of the fact that the 
general practitioners included in Group 1 showed a varying 
degree of interest in taking part in the program. Some showed 
a lot of interest from the start and others not so much, but, 
despite that, there was a good response from all of them a 
few months into the program.
The weakness of this study is the small number of 
patients in Group 2, which could have influenced the results, 
  considering that the health care centers for Group 2 had a 
high number of patients with severe diabetic retinopathy, 
and a low number of patients successfully treated by laser, 
but this can be due only to the limited number of patients 
referred to the nonmydriatic fundus camera unit.
Conclusion
The implementation of a nonmydriatic fundus camera unit 
in our region may help us to control the diabetes   population 
more strictly. Moreover, the inclusion of the general 
practitioner in the screening method (Group 1) seems to 
be important, and a great number of patients with diabetes 
  mellitus were screened, with a higher percentage of patients 
with diabetic retinopathy or macular edema detected.
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